Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tymen T Keller

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cardiovascular Research|October 3, 2003
Infection and inflammation and the coagulation systemMarcel Levi, Tymen T Keller, Eric van Gorp, et al.
Cardiovascular Research|January 11, 2005
Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis researchMartijn D de Kruif, Eric C M van Gorp, Tymen T Keller, et al.
Thrombosis Journal|October 18, 2007
Influenza infection and risk of acute pulmonary embolismMatthijs van Wissen, Tymen T Keller, Brechje Ronkes, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 12, 2006
Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and womenTymen T Keller, Sander I van Leuven, Marijn C Meuwese, et al.
Stroke|December 1, 2007
Selective expansion of influenza A virus-specific T cells in symptomatic human carotid artery atherosclerotic plaquesTymen T Keller, Jelger J van der Meer, Peter Teeling, et al.
Cardiovascular Research|October 3, 2003
Infections and endothelial cellsTymen T Keller, Albert T A Mairuhu, Martijn D de Kruif, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 5, 2005
Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population StudyS Matthijs Boekholdt, Tymen T Keller, Nicholas J Wareham, et al.
Circulation Research|October 28, 2006
Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1Tymen T Keller, Koen F van der Sluijs, Martijn D de Kruif, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cardiovascular Research|October 3, 2003
Infection and inflammation and the coagulation systemMarcel Levi, Tymen T Keller, Eric van Gorp, et al.
Cardiovascular Research|January 11, 2005
Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis researchMartijn D de Kruif, Eric C M van Gorp, Tymen T Keller, et al.
Thrombosis Journal|October 18, 2007
Influenza infection and risk of acute pulmonary embolismMatthijs van Wissen, Tymen T Keller, Brechje Ronkes, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 12, 2006
Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and womenTymen T Keller, Sander I van Leuven, Marijn C Meuwese, et al.
Stroke|December 1, 2007
Selective expansion of influenza A virus-specific T cells in symptomatic human carotid artery atherosclerotic plaquesTymen T Keller, Jelger J van der Meer, Peter Teeling, et al.
Cardiovascular Research|October 3, 2003
Infections and endothelial cellsTymen T Keller, Albert T A Mairuhu, Martijn D de Kruif, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 5, 2005
Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population StudyS Matthijs Boekholdt, Tymen T Keller, Nicholas J Wareham, et al.
Circulation Research|October 28, 2006
Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1Tymen T Keller, Koen F van der Sluijs, Martijn D de Kruif, et al.
Pageof 1